ScienceModerna Says No One Who Took Its Vaccine in Trials Developed Severe COVID Symptoms
The U.S. company will now submit that data to regulators for approval, and tens of millions of doses could be ready before the end of the year.
Got a tip? Send it to The Daily Beast here.